Cohere launches AI health care agents in the U.S.
Cohere, founded in 2019, uses large-language models to build chatbots and generative-AI platforms for enterprise customers to automate some tasks.
The partnership with Ensemble, launched Tuesday, uses a customized version of the North by Cohere platform that will run on health care providers' internal systems and help with tasks such as hospitals appealing insurance-claim denials and chasing down accounts receivable.
The company said pre-launch tests of the tools accelerated denial appeals by 40 per cent and improved denial overturn rates by 15 per cent.
Running on internal systems is a key part of how the AI system protects the safety of patients' information and complies with privacy law, said Cohere co-founder Ivan Zhang.
'There's no data leaving their system, because all the agents are in the house,' he said.
Because of those privacy concerns, Mr. Zhang said the AI has to be trained on synthetic data, which would be similar to real-world data in likeness and structure but without any protected personal information.
The foray into health-care follows Cohere's work in the financial sector, which has to adhere to similar privacy rules. In January, the company announced a partnership with Royal Bank of Canada to co-develop and run a customized platform called North for Banking which, among other things, helps employees answer questions from customers.
Mr. Zhang said Cohere is focused on the U.S. market for now, but hopes to have more to announce for Canadian health-care soon.
'So far, we are focused on the U.S. markets. We want to take these learnings and adapt it to different systems in Canada and globally,' he said.
Cohere did not disclose any financial terms or which U.S. clients are using the AI platform.
The company also received a nod Tuesday from new federal AI minister Evan Solomon.
In a speech in Ottawa, Mr. Solomon outlined the government's new approach to AI, saying it would shift from 'warnings and regulation' to celebrating industry 'champions' such as Cohere.
Mr. Zhang said he was 'delighted' by the support and said there was a strong case to be made that investments in AI were part of strengthening Canada's economy and security.
'We've been very happy about the government's engagement so far,' he said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
7 minutes ago
- CTV News
World IVF Day: The gaps in coverage for B.C. parents
Friday marks World IVF Day, celebrating the first successful IVF birth in 1978 and the advancements in fertility medicine since then. It comes as applications for B.C's publicly funded in vitro fertilization program opened on July 2 and patients are already receiving money. It can cost anywhere from $18,000 to $20,000 for one round of IVF – a medical procedure that involves retrieving a woman's eggs and a man's sperm, combining the two in a lab and transferring the embryo to a woman's uterus. Dr. Beth Taylor is a fertility specialist at Olive Fertility clinic in Vancouver. She says cost is the biggest deterrent to seeking treatment, but the provincial funding is 'not enough.' 'That's always the case, right?' Taylor said. 'It's never enough. So only a small percentage, actually, of our patients will get funding.' Taylor says approximately 500 patients at Olive have already applied, and some have received the money, but there are backlogs and limits to who can access coverage. 'There's two big limits the government has put in place,' she said. 'One is age … A lot of our patients come in their early 40s (and) won't qualify. And the other is financial, so people whose total family income is less than $100,000 will get quite a bit, and then people whose total family incomes (are) more than $250,000 wont get any.' Laura Spencer is a fertility coach and underwent IVF herself in 2015, being forced to pay out of pocket. 'There were 15 months there where people who were anticipating a fully funded cycle (from the province) then find out, when the program starts, it is much less (funding) or they are ineligible all together,' said Spencer. Still, the program has created conversations around fertility and helped to decrease stigma. Dr. Caitlin Dunne is a fertility specialist at Pacific Coastal Reproductive Medicine. 'We just got funding,' she said. 'It's very validating to people who are struggling with infertility to say, 'This is a medical disease, this is worthy of treatment,' and a lot of these patients have renewed hope.' Taylor says she hopes the funding sparks a call for more support for other fertility procedures like egg freezing or covering donor eggs and sperm, as well as surrogacy. 'I think they're going to see the enormous demand for this and the enormous success that comes from this program, so I am optimistic,' she said.
Globe and Mail
7 minutes ago
- Globe and Mail
Chubb Ltd Reports Record Earnings and Strong Growth
Chubb Ltd ((CB)) has held its Q2 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Chubb Ltd's recent earnings call painted a picture of robust financial health, marked by record-breaking earnings per share (EPS), underwriting income, and international premium growth. Despite facing challenges such as competitive pressures in large account property markets and softening financial lines pricing, the overall sentiment was overwhelmingly positive, underscoring the company's strong performance. Record Operating EPS Chubb Ltd achieved a milestone with its core operating EPS reaching a record $6.14, reflecting a 14% increase from the previous year. This impressive growth underscores the company's effective strategies and operational efficiency. Strong Core Operating Income The company reported a record core operating income of $2.5 billion, marking a 13% increase year-over-year. This significant growth highlights Chubb's ability to generate substantial revenue from its core operations. Impressive Underwriting Income Underwriting income soared to $1.6 billion, up 15% from the prior year, resulting in a combined ratio of 85.6%. This improvement indicates a strong underwriting performance and effective risk management. Significant Tangible Book Value Growth Chubb Ltd's tangible book value per share grew by an impressive 23.7% from a year ago and 8% from the previous quarter, showcasing the company's strong financial foundation and shareholder value enhancement. Robust Premium Growth in Life Insurance The Life Insurance division saw premiums grow by nearly 17.5%, reflecting Chubb's successful expansion and market penetration in this sector. Continued Growth in International Markets Chubb's international markets demonstrated strong performance, with premiums in Asia growing over 12.5%, Europe over 8%, and Latin America over 17%. This growth highlights the company's effective global strategy and market diversification. Strong Cash Flow and Investment Income Operating cash flow was robust at $3.2 billion, and adjusted net investment income rose by 8% to nearly $1.7 billion. These figures underscore Chubb's strong cash generation capabilities and investment acumen. Competitive Large Account Property Market The large account-related short-tail business has become increasingly competitive, with softening prices posing challenges. However, Chubb remains focused on maintaining its market position. Property Pricing Pressure Property pricing experienced a decline of 2.5%, with rates down about 7%, offset by an exposure change of 4.9%. This trend reflects the competitive nature of the property market. Softness in Financial Lines Pricing Financial lines pricing faced softness, with a 1.2% decrease in North America and over 6.5% internationally. Chubb continues to navigate these challenges while seeking opportunities for growth. Catastrophe Losses Chubb reported pretax catastrophe losses of $630 million for the quarter, highlighting the impact of unforeseen events on the company's financials. Forward-Looking Guidance Looking ahead, Chubb Ltd remains optimistic about its growth prospects. The company anticipates continued strong financial performance, with a diversified global presence supporting its expansion. The global P&C premiums are expected to grow, with notable increases in consumer P&C and Life Insurance premiums. Despite a competitive U.S. commercial P&C market, Chubb is well-positioned for sustained growth. In conclusion, Chubb Ltd's earnings call reflects a strong positive sentiment, driven by record financial metrics and strategic growth in international markets. While challenges in pricing and competition exist, the company's robust performance and forward-looking strategies suggest a promising future.
CBC
8 minutes ago
- CBC
Manitoba settles lawsuit with family of woman who died after halted medical flight during pandemic
Social Sharing The Manitoba government says it has settled a lawsuit with the family of a woman who died during the COVID-19 pandemic while in the process of being transferred out of province due to a shortage of hospital beds. Matt Wiebe, minister of justice and the province's attorney general, confirmed a settlement was recently reached with the family of Krystal Mousseau more than two years after Mousseau's mother first sued the provincial government and health agencies. Elaine Mousseau alleged that cuts to health care and improper medical decisions contributed to her daughter's death in May 2021. Mousseau was in intensive care with severe COVID-19 pneumonia and died after being taken by ambulance to a waiting airplane that was to take her to Ottawa. Details of the settlement were not made available. Wiebe says he is pleased the province has been able to reach an agreement with the Mousseau family. "While it can't bring back their loved one or repair the harms done to their family, we hope this agreement brings them clarity and a sense of closure," Wiebe said in a statement on Friday. "Our government remains committed to rebuilding health care in northern Manitoba and across our province." Mousseau died on May 25, 2021, after an aborted attempt to fly her from an intensive care unit in Brandon, Man., to a hospital in Ottawa. The province, under the previous Progressive Conservative government, sent dozens of intensive-care patients to other provinces that spring due to a shortage of beds as COVID-19 cases rose and hospitals struggled to deal with an influx of people needing care. Elaine Mousseau alleged that the government and Shared Health, the provincial body that co-ordinates many health services, failed to provide proper care. Shared Health said on Friday that any settlement is confidential in nature and it would not be commenting on the matter. Elaine Mousseau's lawyer was not immediately made available to comment on the settlement. A letter from the regional authority in western Manitoba to the family shortly after Krystal Mousseau's death, which was released publicly, said the transport team did not have a piece of equipment that would let them constantly monitor Mousseau's blood pressure, so a blood-pressure cuff was used instead. Mousseau was also being given at least one medication at the wrong rate, the letter stated. The lawsuit alleged the Tory government ignored warnings in 2019 when it privatized some air ambulance services. The government also created a scenario where hospitals couldn't deal with an influx of patients when it reduced the number of critical care beds in 2019, the lawsuit claimed. The statement of claim also alleged staff at the hospital allowed Mousseau to leave while she was in unstable condition and at severe risk. Mousseau showed high blood pressure and a sudden elevated heart rate shortly before she was put into the ambulance on the way to the airport, the statement of claim alleged. She went into cardiac arrest while in the ambulance, was sent back to hospital, and suffered another cardiac arrest and multiple organ failure before being pronounced dead the next day, the document said.
